Soft matrix promotes immunosuppression in tumor-resident immune cells via COX-FGF2 signaling
Open Access
- 27 May 2025
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-17
Abstract
Mechanical forces of the tumor microenvironment change dynamically during key events of tumorigenesis such as invasion and metastasis. These changes in compressive forces often affect the breast cancer cell phenotype. However, it is lesser known how these dynamic mechanical forces in the tumor microenvironment affect the phenotypes of tumor infiltrated leukocytes (TIL) and their subsequent anticancer activities. Here we find, in primary patient-derived explant cultures (PDEC) containing resident TILs, that low compression promotes a change in the original identity of breast cancer cells from luminal to a more mesenchymal and undifferentiated state. These altered tumor cells induce an upregulation of immunosuppressive cytokines such as interleukin-10 (IL-10) and Transforming Growth Factor Beta (TGF-β), as well as polarization of macrophages towards pro-tumor M2(Gc)-type and depletion of CD8+ effector memory T-cells. These immunosuppressive events are mediated by tumor cell derived fibroblast growth factor 2 (FGF2) and prostaglandin E2 (PGE2). We also find that FGF2 rich areas in primary tumors show enrichment in M2-like-macrophages and diminished numbers of CD8 + T and B-cells. Our results suggest that low compressive forces in the tumor microenvironment induce local immunosuppression via FGF2 secretion arising from phenotypic plasticity of tumor cells.Keywords
This publication has 77 references indexed in Scilit:
- B3GALT6 promotes dormant breast cancer cell survival and recurrence by enabling heparan sulfate-mediated FGF signalingCancer Cell, 2023
- Hot and cold tumors: Immunological features and the therapeutic strategiesMedcomm, 2023
- Comprehensive Integration of Single-Cell DataCell, 2019
- Identification of a mechanogenetic link between substrate stiffness and chemotherapeutic response in breast cancerBiomaterials, 2019
- Organoid Modeling of the Tumor Immune MicroenvironmentCell, 2018
- Developmental signaling pathways regulating mammary stem cells and contributing to the etiology of triple-negative breast cancerBreast Cancer Research and Treatment, 2016
- Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer TherapyCancer Cell, 2015
- Highly Parallel Genome-wide Expression Profiling of Individual Cells Using Nanoliter DropletsCell, 2015
- Tensional homeostasis and the malignant phenotypeCancer Cell, 2005
- Stereoselective cyclooxygenase inhibition in cellular models by the enantiomers of ketoprofenChirality, 1993